{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:38:21Z","timestamp":1786541901307,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017959","name":"Health Commission of Hebei Province","doi-asserted-by":"publisher","award":["20241912"],"award-info":[{"award-number":["20241912"]}],"id":[{"id":"10.13039\/100017959","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mitochondrial DNA (mtDNA) likely contributes to myocardial ischemia-reperfusion injury, yet the prognostic value of its dynamic changes (\u0394mtDNA) for major adverse cardiovascular events (MACE) after percutaneous coronary intervention (PCI) in acute ST-segment elevation myocardial infarction (STEMI) patients remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective study enrolled 236 STEMI patients undergoing emergency PCI. We measured serum mtDNA levels both before and after the procedure to calculate \u0394mtDNA. Based on their \u0394mtDNA values, patients were stratified into three groups: a Low \u0394mtDNA group (T1, \u0394mtDNA\u2009&lt;\u20091.46), an Intermediate \u0394mtDNA group (T2, 1.46\u2009\u2264\u2009\u0394mtDNA\u2009\u2264\u20093.62), and a High \u0394mtDNA group (T3, \u0394mtDNA\u2009&gt;\u20093.62).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During a 1-year follow-up, 58 MACE cases occurred (incidence 24.5%). The Cox proportional hazards model indicated that each standard deviation increase in \u0394mtDNA was associated with a 23.9% higher MACE risk (HR 1.239, 95% CI 1.161\u20131.321,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). When \u0394mtDNA was analyzed by tertiles, the risk displayed a dose-response relationship (P for trend\u2009&lt;\u20090.001). Restricted cubic spline analysis supported a linear positive association (P for nonlinear\u2009=\u20090.263). Survival curves showed significantly different cumulative MACE risks among the \u0394mtDNA groups (Log-rank\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Subgroup analysis revealed a significantly stronger association between \u0394mtDNA and MACE risk in patients treated with \u03b2-blockers or PCSK9 inhibitors (P for interaction\u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates that \u0394mtDNA is significantly associated with post-PCI MACE risk in STEMI patients, an association primarily driven by recurrent angina rather than hard endpoints such as mortality or myocardial infarction. These findings suggest that \u0394mtDNA could serve as an exploratory biomarker to identify patients at elevated risk for ischemia-driven symptomatic events, but its clinical utility requires further validation through formal discrimination analyses and comparisons with established risk scores.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-026-06048-5","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:14:22Z","timestamp":1780618462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preliminary exploration of dynamic changes in circulating mitochondrial DNA (\u0394mtDNA) as a prognostic biomarker for acute ST-segment elevation myocardial infarction patients: a prospective observational study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4661-6812","authenticated-orcid":false,"given":"Shipeng","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3682-5879","authenticated-orcid":false,"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiru","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"6048_CR1","doi-asserted-by":"publisher","first-page":"1520696","DOI":"10.3389\/fcvm.2025.1520696","volume":"12","author":"J Guan","year":"2025","unstructured":"Guan J, Xu Y, Liu L, et al. Assessment of postoperative prognosis in patients with acute ST-segment elevation myocardial infarction after PCI using LRP1. Front Cardiovasc Med. 2025;12:1520696. https:\/\/doi.org\/10.3389\/fcvm.2025.1520696.","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"6048_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.31083\/j.rcm2508294","volume":"25","author":"L Yang","year":"2024","unstructured":"Yang L, Guo J, Chen M, et al. Pan-Immune-Inflammatory value is superior to other inflammatory indicators in predicting inpatient major adverse cardiovascular events and severe coronary artery stenosis after percutaneous coronary intervention in STEMI patients. Rev Cardiovasc Med. 2024;25(8):294. https:\/\/doi.org\/10.31083\/j.rcm2508294.","journal-title":"Rev Cardiovasc Med"},{"issue":"6","key":"6048_CR3","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.3892\/mmr.2020.11558","volume":"22","author":"X Cai","year":"2020","unstructured":"Cai X, Zhang P, Wang S, et al. lncRNA FGD5 antisense RNA 1 upregulates RORA to suppress hypoxic injury of human cardiomyocyte cells by inhibiting oxidative stress and apoptosis via miR\u2013195. Mol Med Rep. 2020;22(6):4579\u201388. https:\/\/doi.org\/10.3892\/mmr.2020.11558.","journal-title":"Mol Med Rep"},{"issue":"1","key":"6048_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12964-025-02603-3","volume":"24","author":"Y Jing","year":"2025","unstructured":"Jing Y, Zhang Y, Kadier T, et al. Mitochondrial DNA release via mPTP and BAX\/BAK drives inflammatory injury in intestinal ischemia reperfusion. Cell Commun Signal. 2025;24(1):50. https:\/\/doi.org\/10.1186\/s12964-025-02603-3.","journal-title":"Cell Commun Signal"},{"key":"6048_CR5","doi-asserted-by":"publisher","unstructured":"Chinese Society of Cardiology of Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology. 2019 Guidelines for the diagnosis and management of acute ST segment elevation myocardial infarction. Chin J Cardiol. 2019, 47(10):766\u2009\u2013\u200983. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-3758.2019.10.003.","DOI":"10.3760\/cma.j.issn.0253-3758.2019.10.003"},{"issue":"2","key":"6048_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5603\/KP.2018.0041","volume":"76","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Kardiol Pol. 2018;76(2):229\u2013313. https:\/\/doi.org\/10.5603\/KP.2018.0041.","journal-title":"Kardiol Pol"},{"key":"6048_CR7","doi-asserted-by":"publisher","first-page":"6608718","DOI":"10.1155\/mi\/6608718","volume":"2025","author":"Y You","year":"2025","unstructured":"You Y, Li Y, Ye L, et al. Interleukins-27 aggravates liver injury by impairing the antimicrobial response of macrophages via the promotion of mitochondrial dysfunction in the context of sepsis. Mediators Inflamm. 2025;2025:6608718. https:\/\/doi.org\/10.1155\/mi\/6608718.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"6048_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13019-016-0481-4","volume":"11","author":"C Qin","year":"2016","unstructured":"Qin C, Gu J, Hu J, et al. Platelets activation is associated with elevated plasma mitochondrial DNA during cardiopulmonary bypass. J Cardiothorac Surg. 2016;11(1):90. https:\/\/doi.org\/10.1186\/s13019-016-0481-4.","journal-title":"J Cardiothorac Surg"},{"key":"6048_CR9","doi-asserted-by":"publisher","first-page":"132579","DOI":"10.1016\/j.ijcard.2024.132579","volume":"417","author":"S Miyamoto","year":"2024","unstructured":"Miyamoto S, Tokuyama T, Okubo Y, et al. Decreased plasma cell-free mitochondrial DNA may be a new biomarker of tachycardia-induced cardiomyopathy in patients with atrial fibrillation. Int J Cardiol. 2024;417:132579. https:\/\/doi.org\/10.1016\/j.ijcard.2024.132579.","journal-title":"Int J Cardiol"},{"key":"6048_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-biochem-032620-104401","volume":"92","author":"LE Newman","year":"2023","unstructured":"Newman LE, Shadel GS. Mitochondrial DNA release in innate immune signaling. Annu Rev Biochem. 2023;92:299\u2013332. https:\/\/doi.org\/10.1146\/annurev-biochem-032620-104401.","journal-title":"Annu Rev Biochem"},{"issue":"7285","key":"6048_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature08780","volume":"464","author":"Q Zhang","year":"2010","unstructured":"Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464(7285):104\u20137. https:\/\/doi.org\/10.1038\/nature08780.","journal-title":"Nature"},{"issue":"1","key":"6048_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI62874","volume":"123","author":"DJ Hausenloy","year":"2013","unstructured":"Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123(1):92\u2013100. https:\/\/doi.org\/10.1172\/JCI62874.","journal-title":"J Clin Invest"},{"key":"6048_CR13","doi-asserted-by":"publisher","first-page":"1526057","DOI":"10.3389\/fcvm.2025.1526057","volume":"12","author":"J Liu","year":"2025","unstructured":"Liu J, Du X, Ren Y, et al. Role of lymphocyte-to-C-reactive protein ratio in forecasting microvascular obstruction in ST-segment elevation myocardial infarction post-percutaneous coronary intervention. Front Cardiovasc Med. 2025;12:1526057. https:\/\/doi.org\/10.3389\/fcvm.2025.1526057.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"6048_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00395-019-0756-8","volume":"114","author":"G Heusch","year":"2019","unstructured":"Heusch G. Coronary microvascular obstruction: the new frontier in cardioprotection. Basic Res Cardiol. 2019;114(6):45. https:\/\/doi.org\/10.1007\/s00395-019-0756-8.","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"6048_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nm.4027","volume":"22","author":"C Lood","year":"2016","unstructured":"Lood C, Blanco LP, Purmalek MM, et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 2016;22(2):146\u201353. https:\/\/doi.org\/10.1038\/nm.4027.","journal-title":"Nat Med"},{"issue":"18","key":"6048_CR16","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1001\/jama.2022.5218","volume":"327","author":"L R\u00e4ber","year":"2022","unstructured":"R\u00e4ber L, Ueki Y, Otsuka T, et al. Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: the PACMAN-AMI randomized clinical trial. JAMA. 2022;327(18):1771\u201381. https:\/\/doi.org\/10.1001\/jama.2022.5218.","journal-title":"JAMA"},{"issue":"4","key":"6048_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/ehjcvp\/pvz022","volume":"5","author":"AA Momtazi-Borojeni","year":"2019","unstructured":"Momtazi-Borojeni AA, Sabouri-Rad S, Gotto AM, et al. PCSK9 and inflammation: a review of experimental and clinical evidence. Eur Heart J Cardiovasc Pharmacother. 2019;5(4):237\u201345. https:\/\/doi.org\/10.1093\/ehjcvp\/pvz022.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"12","key":"6048_CR18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","volume":"17","author":"G Heusch","year":"2020","unstructured":"Heusch G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol. 2020;17(12):773\u201389. https:\/\/doi.org\/10.1038\/s41569-020-0403-y.","journal-title":"Nat Rev Cardiol"},{"issue":"19","key":"6048_CR19","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3390\/cells13191662","volume":"13","author":"V Pellegrini","year":"2024","unstructured":"Pellegrini V, La Grotta R, Carreras F, et al. Inflammatory trajectory of type 2 diabetes: novel opportunities for early and late treatment. Cells. 2024;13(19):1662. https:\/\/doi.org\/10.3390\/cells13191662.","journal-title":"Cells"},{"issue":"10","key":"6048_CR20","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cardfail.2016.06.013","volume":"22","author":"Y Dhondup","year":"2016","unstructured":"Dhondup Y, Ueland T, Dahl CP, et al. Low circulating levels of mitochondrial and high levels of nuclear DNA predict mortality in chronic heart failure. J Card Fail. 2016;22(10):823\u20138. https:\/\/doi.org\/10.1016\/j.cardfail.2016.06.013.","journal-title":"J Card Fail"},{"issue":"1","key":"6048_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11033-025-10369-7","volume":"52","author":"C Daubermann","year":"2025","unstructured":"Daubermann C, Herhaus B, Neuberger EWI, et al. Methodological influences on circulating cell-free-mitochondrial and nuclear DNA concentrations in response to chronic stress. Mol Biol Rep. 2025;52(1):303. https:\/\/doi.org\/10.1007\/s11033-025-10369-7.","journal-title":"Mol Biol Rep"},{"issue":"5","key":"6048_CR22","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1042\/BCJ20170714","volume":"475","author":"H Nakayama","year":"2018","unstructured":"Nakayama H, Otsu K. Mitochondrial DNA as an inflammatory mediator in cardiovascular diseases. Biochem J. 2018;475(5):839\u201352. https:\/\/doi.org\/10.1042\/BCJ20170714.","journal-title":"Biochem J"},{"key":"6048_CR23","doi-asserted-by":"publisher","first-page":"200484","DOI":"10.1016\/j.ijcrp.2025.200484","volume":"27","author":"S Rafiei","year":"2025","unstructured":"Rafiei S, Modarresi-Chahardehi A, Lim V. Circulating-free DNA: a promising tool for early detection of myocardial infarction. Int J Cardiol Cardiovasc Risk Prev. 2025;27:200484. https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200484.","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"6048_CR24","doi-asserted-by":"publisher","first-page":"101848","DOI":"10.1016\/j.mito.2024.101848","volume":"75","author":"A Caicedo","year":"2024","unstructured":"Caicedo A, Benavides-Almeida A, Haro-Vinueza A, et al. Decoding the nature and complexity of extracellular mtDNA: Types and implications for health and disease. Mitochondrion. 2024;75:101848. https:\/\/doi.org\/10.1016\/j.mito.2024.101848.","journal-title":"Mitochondrion"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06048-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06048-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06048-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:06:57Z","timestamp":1786540017000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06048-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6048"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06048-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was reviewed by the Ethics Committee of Hebei Provincial People\u2019s Hospital (Ethics Review No. K-2023-2163). All participants provided written informed consent, authorizing the use of their test results and medical records for scientific research purposes.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"683"}}